These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28935055)

  • 1. Screening and Management of Substance Use in Pregnancy: A Review.
    Cook JL; Green CR; de la Ronde S; Dell CA; Graves L; Morgan L; Ordean A; Ruiter J; Steeves M; Wong S
    J Obstet Gynaecol Can; 2017 Oct; 39(10):897-905. PubMed ID: 28935055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and Effects of Substance Use in Pregnancy.
    Cook JL; Green CR; de la Ronde S; Dell CA; Graves L; Ordean A; Ruiter J; Steeves M; Wong S
    J Obstet Gynaecol Can; 2017 Oct; 39(10):906-915. PubMed ID: 28935056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period.
    Smid MC; Terplan M
    Obstet Gynecol; 2022 Feb; 139(2):317-337. PubMed ID: 34991147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs and pregnancy].
    Halmesmäki E; Kari A
    Duodecim; 1998; 114(20):2109-14. PubMed ID: 11717737
    [No Abstract]   [Full Text] [Related]  

  • 6. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics.
    Kelly R; Zatzick D; Anders T
    Am J Psychiatry; 2001 Feb; 158(2):213-9. PubMed ID: 11156803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the Management of Pregnant Women With Substance Use Disorders.
    McLafferty LP; Becker M; Dresner N; Meltzer-Brody S; Gopalan P; Glance J; Victor GS; Mittal L; Marshalek P; Lander L; Worley LL
    Psychosomatics; 2016; 57(2):115-30. PubMed ID: 26880374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Access to Maternity Care for Women with Opioid Use Disorders: Colocation of Midwifery Services at an Addiction Treatment Program.
    Goodman D
    J Midwifery Womens Health; 2015; 60(6):706-12. PubMed ID: 26769383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidisciplinary management of patients with addictive behavior in a maternity service].
    Edel Y; Foulon C; Samson G
    Soins Pediatr Pueric; 2006; (231):19-21. PubMed ID: 17017642
    [No Abstract]   [Full Text] [Related]  

  • 10. Substance abuse in pregnancy. ACOG Technical Bulletin Number 195--July 1994 (replaces No. 96, September 1986).
    Int J Gynaecol Obstet; 1994 Oct; 47(1):73-80. PubMed ID: 7813759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical components of obstetric management of chemically dependent women.
    Allen PM; Sandler M
    Clin Obstet Gynecol; 1993 Jun; 36(2):347-60. PubMed ID: 8513629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorders in women: special considerations during pregnancy.
    Bolnick JM; Rayburn WF
    Obstet Gynecol Clin North Am; 2003 Sep; 30(3):545-58, vii. PubMed ID: 14664326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial interventions for substance use during pregnancy.
    Brandon AR
    J Perinat Neonatal Nurs; 2014; 28(3):169-77; quiz E1-2. PubMed ID: 25062518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal from mental and psychosocial care during pregnancy.
    Quispel C; Lambregtse-van den Berg M; Kaan M; van den Berg PM; Hoogendijk WJ; Steegers EA; Koudstaal T; Muis I; Bonsel GJ
    J Psychosom Obstet Gynaecol; 2014 Dec; 35(4):140-5. PubMed ID: 25204366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: screening as a tool for engagement.
    Chasnoff IJ; McGourty R
    J Perinatol; 2006 Apr; 26(4):261. PubMed ID: 16570084
    [No Abstract]   [Full Text] [Related]  

  • 17. Perinatal substance abuse treatment. Findings from focus groups with clients and providers.
    Howell EM; Chasnoff IJ
    J Subst Abuse Treat; 1999; 17(1-2):139-48. PubMed ID: 10435262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of drug dependency, overdose, and withdrawal in the obstetric patient.
    Thorp JM
    Obstet Gynecol Clin North Am; 1995 Mar; 22(1):131-42. PubMed ID: 7784035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and addiction: outcomes and interventions.
    McCaul ME; Svikis DS; Feng T
    Md Med J; 1991 Nov; 40(11):995-1001. PubMed ID: 1961100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use in pregnancy: obstetric perspectives.
    Evans AT; Gillogley K
    Clin Perinatol; 1991 Mar; 18(1):23-32. PubMed ID: 2040116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.